Survival After Invasive or Conservative Management of Stable Coronary Disease
Judith S. Hochman(New York University), Zhen Huang(Zhejiang Chinese Medical University), John A. Spertus(Saint Luke's Health System), Yves Rosenberg(National Institutes of Health), Daniel B. Mark(Duke University), Ann Banfield(Northwick Park Hospital), Anna K. Naumova(McGill University Health Centre), Aira Contreras(National Grid (United States)), Harmony R. Reynolds(Anna Needs Neuroblastoma Answers), Gregg W. Stone(Cardiovascular Institute of the South), Shaun G. Goodman(University of Toronto), Yifan Xu(New York University), Shari Esquenazi‐Karonika, David J. Maron(Stanford Medicine), Jonathan Newman(New York University), Mandeep S. Sidhu, Stavroula Mavromichalis(New York University), Roxy Senior(Guy's and St Thomas' NHS Foundation Trust), Sripal Bangalore(New York University), Rebecca Anthopolos(New York University), Robert A. Harrington(Clinical Research Institute), Harvey D. White(University of Auckland), Renato D. Lópes(Duke University), Radosław Pracoń(Institute of Cardiology), William E. Boden(VA New England Healthcare System), Aldo P. Maggioni(Health Care Foundation), Jeffrey S. Berger(New York University), José López‐Sendón(Hospital Universitario La Paz), Ewelina Gwiszcz, Margaret Gilsenan, Kerrie VanLoo, Ying Lü, Arline Roberts, Patenne D. Mathews, Sean M. O’Brien(Duke University), Ruth Kirby(National Heart Lung and Blood Institute), Balram Bhargava(All India Institute of Medical Sciences), Andrea B. Troxel(Andover Eye Associates), Samaa Mohamed, Michelle Chang
Cited by 150
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k